TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$460 Million

Invitae Corp.

Follow-on Offering

Bookrunner, January 2021

Invitae Corp.

Invitae Corporation is a genetic information company that strives to bring comprehensive genetic analysis into mainstream medical practice to improve the quality of healthcare for billions of people. By combining genetic testing services that support patient care throughout life’s journey – from family planning, to proactive health screening, to inherited disease diagnosis – with a unique, rapidly expanding network of patients, healthcare providers, biopharma and advocacy partners, Invitae seeks to capture the broad potential of genetics and expand its use across the healthcare continuum.